Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-08
2011-03-08
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S495000
Reexamination Certificate
active
07902251
ABSTRACT:
The present invention provides pharmaceutical compositions useful in a method for treating neuropathic pain, said method comprising administration of a pain-ameliorating effective amount of the compound according to formula Iwherein R is an alk(en)yl group, R1 is an alkylen(yl) group, n is 0 or 1 and Ar is a carbocyclic aryl group.
REFERENCES:
patent: 4658038 (1987-04-01), Tamir et al.
patent: 6306890 (2001-10-01), Kalgutkar et al.
patent: 2004/0122089 (2004-06-01), Martin et al.
patent: WO 99/23070 (1999-05-01), None
patent: WO03/008632 (2003-01-01), None
patent: WO2005/001041 (2005-01-01), None
Fowler et al. (Biochem Pharmacology, 62, 2001, 517-526).
Huang et al. (Cannabinoids as Therapeutics, Ed. Mecholulam, 2005, p. 149-163).
Schindler, “128. Uber einige in 2-Stellung substituierte 5-Hydroxyindole”, Helvetica Chimica Acta, 1130-1136, 1957.
Jacobsson et al, “Inhibition of Rat C6 Glioma Cell Proliferation by Endogenous and Synthetic Cannabinoids. Relative Involvement of Cannabinoid and Vanilloid Receptors”, Journal of Pharmacology and Experimental Therapeutics, vol. 299, No. 3, Dec. 2001, pp. 951-959.
Bifulco et al, “A new strategy to block tumor growth by inhibiting endocannabinoid inactivation”, FASEB Journal, vol. 18, 2004, pp. 1606-1608.
Bisogno et al, “Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase”, Biochemical and Biophysical Research Communications, 1998, pp. 515-522.
Szallasi et al, “Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse?” Journal of Medicinal Chemistry, vol. 47, No. 11, pp. 2717-2723, 2004.
Suplita et al, “Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: Sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla” Neuropharmacology, Dec. 2005, pp. 1201-1209.
Lynch et al, “Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy-induced neuropathic pain model”, Pain, vol. 110, Jul. 2004-pp. 56-63.
Rodella et al, “AM404, an inhibitor of anadamide reuptake decreases Fox-immunoreactivity in the spinal cord of neuropathic rats after non-oxious stimulation”, European Journal of Pharmacology, vol. 508, Jan. 31, 2005, pp. 139-146.
Capasso et al, “Hydrolase Controls Mouse Intestinal Motility in Vivo”, Gastroenterology, vol. 129, Sep. 2005, pp. 941-951.
De Novellis Vito
De Petrocellis Luciano
Di Marzo Vincenzo
Malone Sabatino
Allergan Inc.
Allergan, Inc.
Condino Debra D.
German Joel B.
Padmanabhan Sreeni
LandOfFree
Method for treating pain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating pain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2660898